Home » Authors » Anette Breindl

Articles by Anette Breindl

Mad Cow Miscreant Necessary For Blood, Neural Self-Renewal

Feb. 23, 2006

By Anette Breindl

Multidrug Resistance Might Be Side Effect Of Bacterial Chats

Feb. 21, 2006

By Anette Breindl

Multidrug Resistance Might Be Side Effect Of Bacterial Chats

Feb. 21, 2006

By Anette Breindl

Metastasis Molecule Yields Second-Generation Targets

Feb. 15, 2006

By Anette Breindl

Metastasis Molecule Yields Second-Generation Targets

Feb. 15, 2006

By Anette Breindl

PDZ Binding Domain Origins Determinant Of Flu Severity

Feb. 9, 2006

By Anette Breindl

PDZ Binding Domain Origins Determinant Of Flu Severity

Feb. 9, 2006

By Anette Breindl

Starting From No Activity Yields New Anti-Alzheimer's Chemical

Jan. 31, 2006

By Anette Breindl

Starting From No Activity Yields New Anti-Alzheimer's Chemical

Jan. 31, 2006

By Anette Breindl

Studying Antibiotic Resistance In Soil, Scientists Hit Pay Dirt

Jan. 24, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 7, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.